Doctor profile · Federal record
Dr. Ashkan Zand, MD
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Internal Medicine Physician · Pasadena, TX
- NPI 1639599632
- Accepts Medicare
- MIPS 88.1 / 100 · 2023
- 12 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
4102 Woodlawn Ave Ste 210
Pasadena, TX 775041949
(832) 240-1189
fax (281) 915-0123 - Additional location
-
10970 Shadow Creek Pkwy Ste 130
Pearland, TX 775840101 - Additional location
-
4126 Southwest Fwy Ste 1210
Houston, TX 770277344 - Mailing address
-
6443 Fairmont Parkway, Ste 140, Pmb 276
Pasadena, TX 77505
Credentials & registration
- NPI registered
- April 2014 — 12 yrs on file
- Profile last updated
- November 27, 2025
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Texas #R1917
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1639599632. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,773
Distinct HCPCS
10
Medicare allowed
$398,129
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 2,614 | 212 | $80 | |
99439 |
Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 657 | 102 | $48 | |
99490 |
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 601 | 108 | $63 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 266 | 217 | $132 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 233 | 101 | $181 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 152 | 88 | $129 | |
G0506 |
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 64 | 62 | $62 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 63 | 33 | $35 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 55 | 53 | $168 | |
93922 |
Ultrasound study of arm and leg arteries | 41 | 40 | $83 |
In context: peer comparison
Among 2 peers in Pasadena Endocrinology, Diabetes & Metabolism Physician, average services per provider: 257. This provider delivers 19× the peer median.Open Payments
Industry payments received
All-time total
$5,197
Transactions
119
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Corcept Therapeutics | 20 | $2,331.04 | |
| Dexcom, INC. | 20 | $609.49 | |
| Abbott Laboratories | 7 | $388.13 | |
| Lilly USA, LLC | 15 | $339.90 | |
| Novo Nordisk INC | 15 | $322.29 | |
| Xeris Pharmaceuticals, INC. | 15 | $283.09 | |
| CeQur Corporation | 1 | $166.34 | |
| Bayer Healthcare Pharmaceuticals INC. | 8 | $151.97 | |
| Amgen INC. | 4 | $143.43 | |
| Radius Health, INC. | 4 | $84.73 | |
| Insulet Corporation | 2 | $59.26 | |
| Sanofi-Aventis U.S. LLC | 2 | $45.65 | |
| Esperion Therapeutics, INC. | 2 | $41.38 | |
| Mannkind Corporation | 2 | $40.57 | |
| Beta Bionics, INC. | 2 | $36.26 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,512
Patients
897
Total drug cost
$2,171,127
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 431 | 140 | $793,980 |
| Levothyroxine Sodium | Generic | 317 | 108 | $7,789 |
| Mounjaro (Tirzepatide) | Brand | 256 | 63 | $489,658 |
| Metformin Hcl ER (Metformin Hcl) | Brand | 229 | 93 | $3,412 |
| Jardiance (Empagliflozin) | Brand | 212 | 72 | $296,151 |
| Atorvastatin Calcium | Generic | 148 | 60 | $2,425 |
| Glipizide | Generic | 145 | 57 | $1,640 |
| Nano 2Nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 113 | 54 | $16,708 |
| Tresiba Flextouch U-200 (Insulin Degludec) | Brand | 106 | 41 | $112,651 |
| Trulicity (Dulaglutide) | Brand | 104 | 26 | $169,198 |
Hospital affiliations
Frequently asked questions
What is Dr. Ashkan Zand's medical specialty?
Dr. Ashkan Zand practices Endocrinology, Diabetes & Metabolism Physician in Pasadena, TX.
Where does Dr. Ashkan Zand practice?
Dr. Ashkan Zand practices at 4102 Woodlawn Ave Ste 210, Pasadena, TX 775041949. Office phone: 8322401189.
What is Dr. Ashkan Zand's NPI?
Dr. Ashkan Zand's National Provider Identifier (NPI) is 1639599632, issued by NPPES.
Does Dr. Ashkan Zand accept Medicare assignment?
Yes. Dr. Ashkan Zand accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ashkan Zand commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS 99439); Chronic care management services (HCPCS 99490). Source: CMS Medicare Physician & Other Practitioners file.